. Author manuscript; available in PMC: 2018 Sep 1.

Published in final edited form as: Depress Anxiety. 2017 Sep 29;34(12):1147–1156. doi: 10.1002/da.22681

Appendix Table 1.

Predicted Changes in Rates and Slopes in Treatment Visits for Depressive Disorder Before and After FDA Black Box Warning, by Race/Ethnicity (n=249)

	White	Black		Latino
	Estimate (SE)	Estimate (SE)	Different from White	Estimate (SE)	Different from White

Baseline Jan 2002 Rate^†	112.54 (2.47)	62.71 (1.72)	^***	41.94(1.46)	^***

Change in rate after warning^Δ	−2.40 (4.20)	−2.07 (2.95)	ns	−4.17 (2.53)	ns

Slope (Δ/month) before warning^‡	0.20 (0.18)	−0.08 (0.13)	ns	0.32 (0.11)^**	ns

Slope (Δ/month) after warning^‡	−0.54 (0.04)^***	0.09 (0.03)^**	^***	0.04 (0.02)	^***

Change in slope	−0.74 (0.19)^***	0.17 (0.13)	^***	−0.29 (0.11)^*	^*

p<0.05,

^**

p<0.01,

^***

p<0.001

^†

Rate is number of treatment visits/10,000 youth per month

^‡

Slope is monthly change in number of treatment visits/10,000 youth

^Δ

Change in rate is level shift between October 2003 and October 2004